Home > Healthcare > Pharmaceuticals > Drug Delivery > Autoinjectors Market

Autoinjectors Market Share

  • Report ID: GMI5412
  • Published Date: Mar 2023
  • Report Format: PDF

Autoinjectors Market Share

Some of the notable key industry players operating in the autoinjectors market include:

  • AbbVie Inc.
  • Mylan
  • GlaxoSmithKline Plc
  • Ypsomed
  • Amgen
  • Becton
  • Dickinson and company
  • Eli Lilly and Company
  • Johnson & Johnson
  • Teva pharmaceuticals
  • Antares Pharma 

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new type development and launches to strengthen type offerings as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market share for autoinjectors was accounted at more than USD 55 billion in 2022 and is expected to record over 13% CAGR from 2023 to 2032.

Autoinjectors market share from the anaphylaxis therapy segment is forecasted to reach over USD 10 billion by end of 2032 owing to the rising prevalence and occurrence of anaphylaxis and food allergies.

Middle East & Africa autoinjectors industry is expected to reach over USD 12 billion by 2032 owing to the significant investments made in the development of new products by regional manufacturers.

AbbVie Inc., GlaxoSmithKline Plc., Mylan, Amgen, Becton, Ypsomed, Dickinson and Company, Eli Lilly and Company, Johnson & Johnson, and Antares Pharma, are some of the leading companies in the autoinjectors business.

Autoinjectors Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 230
  • Countries covered: 15
  • Pages: 175
 Download Free Sample